Authors:
WANG JF
ENGELSBERG BN
JOHNSON SW
WITMER C
MERRICK WC
ROZMIAREK H
BILLINGS PC
Citation: Jf. Wang et al., DNA-BINDING ACTIVITY OF THE MAMMALIAN TRANSLATION ELONGATION COMPLEX - RECOGNITION OF CHROMIUM-DAMAGED AND TRANSPLATIN-DAMAGED DNA, Archives of toxicology, 71(7), 1997, pp. 450-454
Authors:
CRYER JE
JOHNSON SW
ENGELSBERG BN
BILLINGS PC
Citation: Je. Cryer et al., ANALYSIS OF HMG PROTEIN-BINDING TO DNA MODIFIED WITH THE ANTICANCER DRUG CISPLATIN, Cancer chemotherapy and pharmacology, 38(2), 1996, pp. 163-168
Authors:
CHAO JC
WAN XS
ENGELSBERG BN
ROTHBLUM LI
BILLINGS PC
Citation: Jc. Chao et al., INTRACELLULAR-DISTRIBUTION OF HMG1, HMG2 AND UBF CHANGE FOLLOWING TREATMENT WITH CISPLATIN, Biochimica et biophysica acta, N. Gene structure and expression, 1307(2), 1996, pp. 213-219
Authors:
FARID RS
BIANCHI ME
FALCIOLA L
ENGELSBERG BN
BILLINGS PC
Citation: Rs. Farid et al., DIFFERENTIAL BINDING OF HMG1, HMG2, AND A SINGLE HMG BOX TO CISPLATIN-DAMAGED DNA, Toxicology and applied pharmacology, 141(2), 1996, pp. 532-539
Authors:
BILLINGS PC
CRYER JE
MOY LY
ENGELSBERG BN
Citation: Pc. Billings et al., A POST-LABELING TECHNIQUE FOR THE IODINATION OF DNA-DAMAGE RECOGNITION PROTEINS, Cancer biochemistry biophysics, 14(4), 1995, pp. 223-230
Authors:
LAWRENCE DL
ENGELSBERG BN
FARID RS
HUGHES EN
BILLINGS PC
Citation: Dl. Lawrence et al., LOCALIZATION OF THE BINDING REGION OF HIGH-MOBILITY GROUP PROTEIN-2 TO CISPLATIN-DAMAGED DNA, The Journal of biological chemistry, 268(32), 1993, pp. 23940-23945